Literature DB >> 21984010

The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.

Dodi Safari1, Huberta A T Dekker, Ger T Rijkers, Arie van der Ende, Johannis P Kamerling, Harm Snippe.   

Abstract

The structures of the branched capsular polysaccharides of group B streptococcus type III (GBSIIIPS) and Streptococcus pneumoniae type 14 (Pn14PS) are identical apart from the (α2→3)-linked sialic acid in the side chains of GBSIIIPS. The present study tries to determine the minimal epitope in GBSIIIPS, using both a panel of anti-Pn14PS mouse sera and sera of humans vaccinated with either Pn14PS or GBSIIIPS. Type-specific Pn14PS antibodies that recognize the branched structure of Pn14PS have a low affinity for the native GBSIIIPS. Desialylation of GBSIIIPS results in dramatically higher affinity of anti-Pn14PS antibodies. Epitope specific anti-Pn14PS mouse antibodies and human sera of PCV7 vaccinees only recognized structures with the branching element -Glc-(Gal-)GlcNAc-, in particular -Gal-Glc-(Gal-)GlcNAc- in Pn14PS. On the other hand anti-GBSIIIPS human antibodies recognize predominantly the linear structure in the backbone of Pn14PS or GBSIIIPS, i.e., -Glc-GlcNAc-Gal-. This difference in antigenicity of Pn14PS and GBSIIIPS is in agreement with the difference in flexibility of the two polysaccharides caused by the presence or absence of sialic acid. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984010     DOI: 10.1007/s10719-011-9354-1

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  12 in total

1.  Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: the role of sialic acid.

Authors:  Jorge González-Outeiriño; Renuka Kadirvelraj; Robert J Woods
Journal:  Carbohydr Res       Date:  2005-04-11       Impact factor: 2.104

2.  Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae.

Authors:  Renuka Kadirvelraj; Jorge Gonzalez-Outeiriño; B Lachele Foley; Meredith L Beckham; Harold J Jennings; Simon Foote; Michael G Ford; Robert J Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-16       Impact factor: 11.205

3.  Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  D L Kasper; L C Paoletti; M R Wessels; H K Guttormsen; V J Carey; H J Jennings; C J Baker
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

4.  Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.

Authors:  Hilde-Kari Guttormsen; Carol J Baker; Moon H Nahm; Lawrence C Paoletti; Susu M Zughaier; Morven S Edwards; Dennis L Kasper
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

Authors:  Dodi Safari; Huberta A T Dekker; John A F Joosten; Dirk Michalik; Adriana Carvalho de Souza; Roberto Adamo; Martina Lahmann; Andreas Sundgren; Stefan Oscarson; Johannis P Kamerling; Harm Snippe
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

6.  Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.

Authors:  H J Jennings; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1981-08-04       Impact factor: 3.162

7.  Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.

Authors:  Shannon Weiman; Samira Dahesh; Aaron F Carlin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Glycobiology       Date:  2009-07-30       Impact factor: 4.313

8.  Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.

Authors:  M R Wessels; V Pozsgay; D L Kasper; H J Jennings
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

9.  Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.

Authors:  Fatme Mawas; Jutta Niggemann; Christopher Jones; Michael J Corbel; Johannis P Kamerling; Johannes F G Vliegenthart
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Immunodeterminant specificity of human immunity to type III group B streptococcus.

Authors:  D L Kasper; C J Baker; R S Baltimore; J H Crabb; G Schiffman; H J Jennings
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  4 in total

1.  Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.

Authors:  Francesco Berti; Edmondo Campisi; Chiara Toniolo; Laura Morelli; Stefano Crotti; Roberto Rosini; Maria Rosaria Romano; Vittoria Pinto; Barbara Brogioni; Giulia Torricelli; Robert Janulczyk; Guido Grandi; Immaculada Margarit
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

2.  Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.

Authors:  Seth H Pincus; Emily Moran; Grace Maresh; Harold J Jennings; David G Pritchard; Marianne L Egan; Ola Blixt
Journal:  Vaccine       Date:  2012-05-23       Impact factor: 3.641

3.  Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide.

Authors:  Filippo Carboni; Roberto Adamo; Monica Fabbrini; Riccardo De Ricco; Vittorio Cattaneo; Barbara Brogioni; Daniele Veggi; Vittoria Pinto; Irene Passalacqua; Davide Oldrini; Rino Rappuoli; Enrico Malito; Immaculada Y Ros Margarit; Francesco Berti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

4.  Automated glycan assembly of Streptococcus pneumoniae type 14 capsular polysaccharide fragments.

Authors:  João Louçano; Peter Both; Andrea Marchesi; Linda Del Bino; Roberto Adamo; Sabine Flitsch; Mario Salwiczek
Journal:  RSC Adv       Date:  2020-06-22       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.